With breakthrough discoveries in fields like biotech, material science, and energy, deep tech startups are driving the next wave of technological change. These startups are working on groundbreaking innovations in fields like artificial intelligence, robotics, genomics, and quantum computing that have the potential to profoundly disrupt industries and society.
What are deep tech startups?
Deep tech startups aim to create new markets and find novel solutions to difficult problems rather than iterate on existing technologies.
DeepDrive
Founded in 2021, DeepDrive is a company that makes state-of-the-art electric motors. As vehicles and machines shift towards electric power, DeepDrive is on the cutting edge in designing next-generation e-motors. The company was founded by engineers with decades of experience in vehicle electrification. At DeepDrive, they are rethinking how electric motors are engineered specifically for use in cars, trucks, boats, and industrial equipment.
Their motors provide more torque in a smaller, lighter package to improve the power and range capabilities of electric vehicles. Precision control software helps DeepDrive motors optimize energy usage as well.
The Mobility House
The Mobility House develops smart grid technologies optimizing electric vehicle batteries as both transportation and power sources. Their specialized charging platforms and energy management software integrate stationary and mobile storage by coordinating EV charging with broader grid conditions.
This vehicle-to-grid integration intelligently charges car batteries when electricity prices are low and feeds electricity back to the grid to help stabilize peak demands. The Mobility House’s optimized control of this enormous distributed battery capacity unlocks new value streams while supporting renewable energy growth. With efficient bidirectional flow orchestrating EV and grid harmony, the company paves the way for a cleaner, more resilient energy future underpinned by the coming wave of electric mobility.
Myricx Pharma
Founded by scientists in 2018, Myricx leverages proprietary AI-based platforms to design promising inhibitor drug candidates computationally. This accelerates the timeline from hypothesis to first-in-human testing to make breakthrough treatments available faster to patients.
Areas of research include rare pediatric illnesses, neurodegeneration, and precision oncology. Myricx pursues indications often overlooked commercially. Each project carefully balances inventiveness with pragmatic validation steps to progress steadily from compound library through animal models into clinical trials.
Enterome
Founded in 2012, Enterome’s proprietary discovery platform analyzes the composition and functionalities of the gut microbiome to identify new disease pathways and derive medicinal candidates modulating key bacterial and immune processes.
By tapping into the vast biodiversity of microbiome-derived compounds, Enterome expands therapeutic possibilities beyond conventional drug classes. Their bioinformatics and lab capabilities extract unique insights from trillions of bacteria.
Splice Bio
Founded by intein pioneer Dr. Sridhar Ramaswamy in 2018, Splice Bio has developed a suite of tools based on their discoveries around how inteins can precisely edit proteins inside living cells. Their programmable “molecular scissors” have diverse applications.
Splice Bio aims to propel medicine and bioengineering forward by unlocking the possibilities opened by directly manipulating proteins – the functional units of life. Their intein technologies provide the programmable means to reshape proteins according to novel designs.
Automata
Founded in 2020, Automata offers an intelligent benchtop robot system capable of automating complex multi-step protocols like DNA assembly, cell culturing, and compound screening without human intervention. Their goal is to accelerate R&D.
By automating error-prone manual labor, Automata’s technology enables scientists to execute more experiments faster and more precisely. Labs can parallelize work and free up human focus for higher value initiatives.
Coave
Founded in 2019, Coave engineering next-gen AAV vectors capable of targeting key tissues in the eye and brain to deliver corrective genes that compensate for mutations causing vision loss, neurodegeneration, and other devastating effects.
By applying cutting-edge capsid engineering and optimization to overcome key gene delivery challenges, Coave aims to translate recent vector advancements into transformative new therapies for untreated diseases. Their platform integrates across discovery and development.
Epsilogen
Founded in 2019, Epsilogen combines computational antibody design with high-throughput screening to rapidly develop IgG candidates targeting tumor neoantigens while minimizing adverse responses. Their platform integrates AI and experimentation.
By accelerating discovery of engineered antibodies that stimulate targeted anti-cancer immunity, Epsilogen aims to unlock the full potential of immunotherapy while avoiding dangerous side effects associated with current immunomodulators.
LabGenius
Founded in 2020, LabGenius leverages AI and automation to accelerate drug discovery. Their EVATM platform iteratively designs, tests, and learns from protein variants to optimize therapeutic candidates.
By predicting protein mutations in silico, LabGenius can explore a wider design space than conventional methods alone. This machine learning approach rapidly yields novel proteins unattainable through manual screening.
Outsight
Founded in 2017, Outsight produces cameras that use sensor-fusion technology to capture detailed 3D and semantic environment data in real-time. Their technology perceives space and activity with holistic context.
By enabling comprehensive machine perception, Outsight aims to upgrade autonomous system decision-making across industries from automotive to security. More intuitive hardware promises to enhance efficiency and safety.
Precirix
Founded in 2019, Precirix designs and optimizes radiopharmaceuticals using computational platforms and lab automation to accelerate discovery. Their drugs combine radioactive isotopes with tumor-targeting antibodies.
By synthesizing and screening drug candidates faster, Precirix aims to discover more effective precision radio-immunotherapies that specifically eliminate tumor cells while minimizing side effects.
Wandercraft
Founded in 2012, Wandercraft engineers lightweight exoskeletons allowing users with lower body disabilities to stand and walk with minimal compensation. Their technology aims to blend seamlessly into users’ motions.
By developing intelligent assistive devices designed holistically around patients’ lifestyles and goals, Wandercraft seeks to make standing and walking accessible to more people.
Comand AI
Founded in 2020, Comand AI develops AI solutions tailored for military purposes like predictive maintenance, supply chain optimizations, and information processing. Their applications promise to enhance readiness and operations.
By thoughtfully integrating AI to augment key processes, Comand seeks to help forces accomplish missions more effectively while reducing risks to personnel. Their technology provides enhanced intelligence to human teams.
Scenic Biotech
Founded in 2017 as a Carlsberg/ETH Zürich spinout, Scenic Biotech expedited translating their genomics innovation into drug discovery. Backed by a renowned geneticist and industry veterans, Scenic is progressing new therapeutic modalities to cure elusive genetic conditions.
Now with a pipeline of preclinical programs, a strategic Genentech partnership, and seasoned leadership experienced enabling genetic medicines, Scenic is demonstrating the immense possibilities unleashed by genetic suppressors. Their platform illuminates biology’s opaque dimensions.
WeMaintain
Founded in 2018, WeMaintain modernizes fragmented, analog service coordination plaguing owners and operators of far-flung physical assets. Their technology simplifies centralizing and controlling distributed workforces.
Early customers validate demand for digitally transforming field operations using workforce management and data. As service models shift, WeMaintain provides the logistics infrastructure needed.
7bridges
Founded in 2018, 7bridges applies new data science approaches to modernize supply chain operations still reliant on static legacy systems. Their technology leverages real-time data for continuous improvement and adaptation not possible before.
Global shippers like Unilever and carriers like Indian Railways partner with 7bridges as supply chain volatility increases worldwide. As supply ecosystems become dynamic, their AI and algorithms drive smarter decisions.
Cognite
Founded in 2017, Cognite tackles head-on the messy data operations challenge blocking industrial firms from digitally transforming. Their product provides the missing data layer required for scalable IIoT applications.
With pioneers like OMV, Aker BP, and Odfjell as clients, Cognite is proving the transformative power of standardized, contextualized data applied through partnerships. Their technology demonstrates the art of the possible with IIoT.
Dixa
Founded in 2015, Dixa was an early disruptor of legacy call center software using messaging and conversational experiences better aligned with modern customer expectations. Their platform pioneered support delivered through customers’ preferred communication channels.
With major clients like Toyota, telenor, and Carlsberg, Dixa is at the forefront of customer experience innovations using conversational AI to elevate human-centricity. As customers embrace messaging, Dixa provides the platform to connect.
Flexciton
Founded in 2020 by former physicists and machine learning experts from IBM Research, Flexciton brings unique big data and AI approaches to overcome inefficiencies that have plagued semiconductor manufacturing. Their platform delivers intelligence needed to master process complexity.
Early partners adopting Flexciton include fabrication facilities and equipment makers seeking to benefit from optimizing tool synergy. As next-gen chipmaking progresses, Flexciton provides the analytics brains to maximize billion-dollar investments.
Gourmey
Founded in 2019, Gourmey pioneers manufacturing methods to produce real foie gras and other meat from animal cells without slaughter. Their process aims for lower carbon emissions than industrial animal agriculture.
Key innovations include proprietary animal cell isolation, growth mediums, bioreactors, and food processing techniques to replicate meat qualities like taste, texture, and nutrition completely. This provides the sensation of foie gras without the animal.
Humanising Autonomy
Founded in 2018, Humanising Autonomy applies behavioral science and design thinking to develop natural visual languages enabling intuitive human-AI collaboration. Their frameworks guide how intelligent systems communicate and act with people.
Key products include machine readable libraries of animations and 3D gestures for safe, transparent AI interactions across service applications like self-driving vehicles, robotics, and automated workplaces. This establishes shared conventions as AI integrates into human environments.
Karakuri
Founded in 2018, Karakuri has created autonomous modular food assembly stations designed to integrate into existing restaurant kitchens. Their robots can work collaboratively with staff on repetitive tasks like burger and salad preparation.
Key innovations include computer vision, machine learning, and specialized food gripping technologies to enable versatile robotic food prep and cooking. This automates volume production without dedicated programming.
Medlumics
Founded in 2016, Medlumics applies light-based sensing to create non-invasive medical devices for continuous monitoring and diagnostics. Their photonic sensors track vital biomarkers through the skin for applications like glucose monitoring, cardiorespiratory assessment, and neonatal care.
Key innovations include proprietary integrated photonics chips and wearable sensor arrays powered by machine learning data analysis. This enables precise, real-time monitoring without cumbersome blood draws or equipment.
Conclusion
With innovations in areas like renewable energy, biotech, autonomous vehicles, and more, deep tech startups are driving the next wave of technological change. Though still relatively nascent, the deep tech sector promises to yield important new companies and technologies that could transform the future.
Discover more creative startups that might interest you:
- Top business intelligence startups that are making waves in the industry.
- Revolutionary neuroscience startups enhancing the industry with amazing innovations.
- Successful sheet metal companies with the smartest techniques of metal fabrication.
- Blooming HR startups modernizing talent management through innovation.
- Unique Generative AI startups that are going to without a doubt change the world.
Related Articles
10 rules for success from Jack Ma
Success can only be explained by the successful. That’s why we turned to the 10 rules for success Jack Ma swear by.
The ultimate guide to writing a B2B business proposal
Your B2B business proposal is the key to building profitable partnerships. We prepared a guide on sales proposal best practices.
17 B2B marketing tips in 2025 (Backed by experts)
Build your marketing strategy based on these proven B2B marketing tips. Besides that, find out which are the B2B marketing trends that guarantee success in 2025.
10 rules for success from Jack Ma
Success can only be explained by the successful. That’s why we turned to the 10 rules for success Jack Ma swear by.
The ultimate guide to writing a B2B business proposal
Your B2B business proposal is the key to building profitable partnerships. We prepared a guide on sales proposal best practices.